Concurrent with the Bankruptcy Filing, Greg Kress, the Company’s chief executive officer, Alberto Recchi, the Company’s chief financial officer, and Andy Nied, the Company’s chief operating officer, resigned as executive officers of the Company.
Departed
Greg Kress
Chief Executive Officer
Shapeways Holdings, Inc.
Effective
2024-07-02
Filed
July 3, 2024, 7:59 PM ET
Concurrent with the Bankruptcy Filing, Greg Kress, the Company’s chief executive officer, Alberto Recchi, the Company’s chief financial officer, and Andy Nied, the Company’s chief operating officer, resigned as executive officers of the Company.
• Brandon Hetzel, Chief Financial Officer and, for purposes of Section 16 and filings with the Securities and Exchange Commission, Principal Accounting Officer;
On June 27, 2024, the Board of Directors (the “Board”) of the Company appointed Heather Rees, previously the Company’s Senior Vice President, Finance and Accounting, to serve as Chief Financial Officer and to continue serving as principal financial and accounting officer, effective immediately.
the Board of Directors appointed James Clavijo as Chief Financial Officer ("CFO"), principal financial officer and principal accounting officer of Mannatech Incorporated (the "Company") effective July 1, 2024.
Landen Fredrick, the Company’s Chief Executive Officer, who served as the Company's interim CFO since January 2024, will relinquish the role to Mr. Clavijo.
On June 27, 2024, the Board of Directors (the “Board”) of Investcorp Credit Management BDC, Inc. (the “Company”) accepted the resignation of Peter Sattelmair from his position as Chief Financial Officer of the Company, effective July 1, 2024.
On July 2, 2024, the Board of Directors of the Company appointed Liat Zalts, age 40, to serve as the Company’s Chief Financial Officer and Treasurer effective as of September 30, 2024.
On June 30, 2024, Ms. Chen Franco-Yehuda notified Pluri Inc. (the “Company”) of her resignation from her position as Chief Financial Officer, Treasurer and Secretary of the Company, which will become effective as of September 30, 2024.
On June 27, 2024, Stephanie Poe, Chief Financial Officer, Secretary and Treasurer of Smith-Midland Corporation (the “Company”), notified the Company of her decision to resign from her positions with the Company, effective July 17, 2024.
On July 1, 2024, the Company announced that Dan Geddes will be appointed to the position of Group Executive Vice President and Chief Financial Officer effective as of January 1, 2025.
Departed
Jerry Salinas
Executive Vice President, Chief Financial Officer and Chief Accounting Officer
On July 1, 2024, Jerry Salinas notified Cullen Frost Bankers, Inc. (the “Company”) of his intention to retire as Executive Vice President, Chief Financial Officer and Chief Accounting Officer of the Company and Frost Bank effective as of December 31, 2024.
Sunil M. Doshi, the Chief Financial Officer (principal financial and accounting officer) (“CFO”) and Treasurer of Fossil Group, Inc. (the “Company”), notified the Company of his intent to resign from the Company, effective July 19, 2024.
On June 27, 2024, Thomas A. George, Genesco Inc.’s (the “Company”) chief financial officer and senior vice president – finance, was appointed to serve in the additional role of the Company’s principal accounting officer
On June 28, 2024, Freddie Mac (formally the Federal Home Loan Mortgage Corporation) appointed James Whitlinger as the company’s Interim Chief Financial Officer, effective June 29, 2024.
Jeffrey J. Deuel, who has served as CEO of Heritage Bank since 2018 and CEO of Heritage since 2019, will remain CEO of Heritage until May 2025, at which time he will be become a non-officer employee of Heritage.
On July 1, 2024, Greene County Bancorp, Inc. (the “Company”), the holding company of The Bank of Greene County (the “Bank”), announced the appointment of Nick Barzee as Senior Vice President and Chief Financial Officer of the Company.
Mr. Sheahan, the current Chairman, President, and Chief Executive Officer of Cambridge, additionally will serve as Chief Executive Officer of the Company effective upon and subject to the closing of the Merger.
Departed
Brian C. Witherow
Executive Vice President and Chief Financial Officer
CEDAR FAIR L P
Effective
2024-07-01
Filed
July 1, 2024, 7:59 PM ET
Additionally, on the Closing Date and as a result of the Mergers, each of Richard A. Zimmerman (President and Chief Executive Officer), Tim Fisher (Chief Operating Officer), Brian C. Witherow (Executive Vice President and Chief Financial Officer), Brian Nurse (Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary), David R. Hoffman (Senior Vice President and Chief Accounting Officer) and Monica Sauls (Senior Vice President and Chief Human Resources Officer) ceased to serve as officers of the General Partner.
Departed
Richard A. Zimmerman
President and Chief Executive Officer
CEDAR FAIR L P
Effective
2024-07-01
Filed
July 1, 2024, 7:59 PM ET
Additionally, on the Closing Date and as a result of the Mergers, each of Richard A. Zimmerman (President and Chief Executive Officer), Tim Fisher (Chief Operating Officer), Brian C. Witherow (Executive Vice President and Chief Financial Officer), Brian Nurse (Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary), David R. Hoffman (Senior Vice President and Chief Accounting Officer) and Monica Sauls (Senior Vice President and Chief Human Resources Officer) ceased to serve as officers of the General Partner.
Appointed
Frederick A. Cromer
Executive Vice President and Chief Financial Officer
On June 25, 2024, Versus Systems, Inc. (the “Company”) Chief Executive Officer and Director Matthew Pierce, Chair of the Board Keyvan Peymani, Chief Financial Officer Craig Finster, and independent directors Michelle Gahagan and Shannon Pruitt tendered their resignations from the Company, effective immediately.
On June 25, 2024, Versus Systems, Inc. (the “Company”) Chief Executive Officer and Director Matthew Pierce, Chair of the Board Keyvan Peymani, Chief Financial Officer Craig Finster, and independent directors Michelle Gahagan and Shannon Pruitt tendered their resignations from the Company, effective immediately.
Appointed
Curtis Wolfe
Chief Executive Officer and Chief Financial Officer
J. Ted Nissen will become Chief Executive Officer of the Bank
Departed
Bo Kruse
Chief Financial Officer and Treasurer
Y-mAbs Therapeutics, Inc.
Effective
2024-07-31
Successor
Peter Pfreundschuh
Filed
July 1, 2024, 7:59 PM ET
succeeded Bo Kruse, who is expected to remain available to the Company for a period of time following the conclusion of his employment on July 31, 2024, during which time Mr. Kruse will assist in the transition of his responsibilities and duties.
Appointed
Peter Pfreundschuh
Chief Financial Officer and Treasurer
Y-mAbs Therapeutics, Inc.
Effective
2024-06-28
Filed
July 1, 2024, 7:59 PM ET
On June 27, 2024, the Board of Directors (the “Board”) of Y-mAbs Therapeutics, Inc. (the “Company”) appointed Peter Pfreundschuh to serve as the Company’s Chief Financial Officer and Treasurer, effective June 28, 2024 (the “Effective Date”).
On July 1, 2024, Tim Sheehy, President, Chief Executive Officer, and director of the Company, notified the Company of his decision to resign from his position as President, Chief Executive Officer, and from the Board, effective immediately.
Appointed
(interim)
Osman H. Ahmed
Interim Chief Executive Officer
Rubicon Technologies, Inc.
Effective
2024-06-28
Filed
July 1, 2024, 7:59 PM ET
On June 27, 2024, the Company entered into an Employment Agreement (the “Employment Agreement”) entered into between the Company and Mr. Osman H. Ahmed, wherein the Company offered Mr. Ahmed the position of Interim Chief Executive Officer.
Departed
Phil Rodoni
Chief Executive Officer
Rubicon Technologies, Inc.
Effective
2024-06-28
Successor
Osman H. Ahmed
Filed
July 1, 2024, 7:59 PM ET
On June 27, 2024, Mr. Phil Rodoni and the Company entered into a Separation Agreement (the “Separation Agreement”) wherein Mr. Rodoni resigned from his role as Chief Executive Officer of Rubicon Technologies, Inc. (the “Company”), effective June 28, 2024.
Departed
Ebrahim “Eboo” Versi
Chief Executive Officer
DMK PHARMACEUTICALS Corp
Effective
2024-06-27
Filed
July 1, 2024, 7:59 PM ET
Also effective June 27, 2024, Mr. Versi was separated from his role as Chief Executive Officer of the Company
The Board authorized the Company to extend an offer of employment to Mr. George Scherff to succeed Mr. Knapper as Chief Executive Officer of the Company
On June 27, 2024, Mr. Gene Mack (“Mr. Mack”), the Company’s current Chief Financial Officer, was appointed to serve as Interim Chief Executive Officer (“Interim CEO”), effective as June 25, 2024, to fill the vacancy created by Mr. Alder’s departure as Chief Executive Officer.
On June 25, 2024, Matthias Alder (“Mr. Alder”), Chief Executive Officer of Gain Therapeutics, Inc. (the “Company”), and the Company mutually agreed that his service as Chief Executive Officer of the Company would terminate so that Mr. Alder can pursue other opportunities.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.